Case Report
A pediatric case of exudative erythema multiforme probably associated with asymptomatic COVID-19
Downloads
- Download
Copyright
The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.
License
Trends in Immunotherapy (TI) publishes accepted manuscripts under Creative Commons Attribution 4.0 International (CC BY 4.0). Authors who submit their papers for publication by TI agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source are properly cited, anyone may copy, redistribute, reuse, and transform the content.
COVID-19 is a pandemic involving severe acute respiratory syndrome-coronavirus SARS-CoV-2, which started in China at the end of 2019 and has spread globally. Among COVID-19 patients, 17.8% are under 20 years of age. Most children infected with SARS-CoV-2 are asymptomatic or only oligosymptomatic and can easily be overlooked. We followed an 11-year-old boy showing exudative erythema multiforme, which appeared during isolation at home following a positive polymerase chain reaction (PCR) test for COVID-19. Our case, although otherwise asymptomatic, showed typical clinical and histological manifestations of the erythema multiforme-like lesions associated with COVID-19. The presence of such an asymptomatic SARS-CoV-2 carrier who developed erythema multiforme-like skin lesions provides the possibility that some undefined infectious organisms, such as SARS-CoV-2, could be the origin of exudative erythema multiforme cases without any apparent cause.
Keywords:
COVID-19 severe acute respiratory syndrome-coronavirus-2 polymerase chain reaction asymptomatic exudative erythema multiformeReferences
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. Journal of the American Medical Association 2020; 323(13): 1239–1242. doi: 10.1001/jama.2020.2648
- Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M. Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article. Dermatologic Therapy 2021; 34: e14554. doi: 10.1111/dth.14554
- Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review. eClinicalMedicine 2020; 24: 100433. doi: 10.1016/j.eclinm.2020.100433
- Parri N, Lenge M, Buonsenso D. Children with Covid-19 in pediatric emergency departments in Italy. The New England Journal of Medicine 2020; 383(2): 187–190. doi: 10.1056/NEJMc2007617
- Li H, Zhao Y, Zhou L. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: What do we know after 10 months under this pandemic? International Journal of Dermatology 2022; 61: 39–45. doi: 10.1111/ijd.15882
- Wollina U, Karadağ AS, Rowland-Payne C, et al. Cutaneous signs in COVID-19 patients: A review. Dermatologic Therapy 2020; 33(5): e13549. doi: 10.1111/dth.13549
- Torrelo A, Andina D, Santonja C, et al. Erythema multiforme-like lesions in children and COVID-19. Pediatric Dermatology 2020; 37(3): 442–446. doi: 10.1111/pde.14246